-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA APPROVES BELZUTIFAN IN COMBINATION WITH LENVATINIB FOR ADVANCED RENAL CELL CARCINOMA WITH A CLEAR CELL COMPONENT

Reuters·09/24/2026 19:18:02